Double Medical Technology's conservative balance sheet indicates easy debt elimination. However, last year's loss and shrinking revenue make it a risky investment. Likely, the company will need to raise capital again soon.
Despite a recent drop, Double Medical Technology's P/S ratio remains high due to strong future growth expectations. Investors believe the potential for revenue deterioration is remote, justifying the high P/S ratio. These conditions, if persistent, will continue to support the share price.
大博醫療股票討論區
暫無評論